Live Breaking News & Updates on Ptc therapeutics inc

Stay informed with the latest breaking news from Ptc therapeutics inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ptc therapeutics inc and stay connected to the pulse of your community

PTC Therapeutics (NASDAQ:PTCT) Shares Gap Up Following Better-Than-Expected Earnings

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) gapped up prior to trading on Friday following a better than expected earnings announcement. The stock had previously closed at $25.49, but opened at $27.00. PTC Therapeutics shares last traded at $27.60, with a volume of 86,284 shares. The biopharmaceutical company reported ($1.20) earnings per share (EPS) […]

Wellington , New-zealand-general- , New-zealand , Canada , United-states , Matthewb-klein , Cantor-fitzgerald , Ptc-therapeutics-inc , Royal-bank , Armistice-capital , Jefferies-financial-group

PTC Therapeutics, Inc. (NASDAQ:PTCT) CEO Matthew B. Klein Sells 3,361 Shares

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) CEO Matthew B. Klein sold 3,361 shares of the stock in a transaction that occurred on Friday, April 19th. The stock was sold at an average price of $24.89, for a total value of $83,655.29. Following the transaction, the chief executive officer now owns 225,807 shares in […]

Canada , China , United-states , Texas , Matthewb-klein , Zurcher-kantonalbank-zurich-cantonalbank , Securities-exchange-commission , Therapeutics-company-profile , Sg-americas-securities , Therapeutics-inc , Cantor-fitzgerald , Allspring-global-investments-holdings

PTC Therapeutics, Inc. (NASDAQ:PTCT) CEO Sells $19,785.18 in Stock

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) CEO Eric Pauwels sold 787 shares of PTC Therapeutics stock in a transaction dated Wednesday, April 17th. The stock was sold at an average price of $25.14, for a total value of $19,785.18. Following the transaction, the chief executive officer now owns 67,694 shares in the company, […]

United-states , Canada , Eric-pauwels , Walleye-capital , Jacobs-levy-equity-management-inc , Cantor-fitzgerald , Jefferies-financial-group , Therapeutics-inc , Charles-schwab-investment-management-inc , Ptc-therapeutics-inc , Vanguard-group-inc , Nasdaq

Matthew B. Klein Sells 3,361 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) Stock

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) CEO Matthew B. Klein sold 3,361 shares of the stock in a transaction dated Friday, April 19th. The shares were sold at an average price of $24.89, for a total transaction of $83,655.29. Following the completion of the transaction, the chief executive officer now directly owns 225,807 […]

China , United-states , Canada , Matthewb-klein , Nasdaq , Ptc-therapeutics-inc , Royal-bank , Allspring-global-investments-holdings , Therapeutics-inc , Headlands-technologies , Jefferies-financial-group

Matthew B. Klein Sells 3,361 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) Stock

Matthew B. Klein Sells 3,361 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China , United-states , Canada , Matthewb-klein , Nasdaq , Ptc-therapeutics-inc , Royal-bank , Headlands-technologies , Therapeutics-inc , Allspring-global-investments-holdings , Hexagon-capital-partners

PTC Therapeutics (NASDAQ:PTCT) Shares Gap Down to $24.69

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report)’s share price gapped down before the market opened on Friday . The stock had previously closed at $24.69, but opened at $24.01. PTC Therapeutics shares last traded at $24.98, with a volume of 66,571 shares trading hands. Analysts Set New Price Targets Several equities research analysts have […]

Canada , China , United-states , Allan-steven-jacobson , Royal-bank , Therapeutics-inc , Allspring-global-investments-holdings , Nisa-investment-advisors , Hexagon-capital-partners , Therapeutics-company-profile , Cantor-fitzgerald , Securities-exchange-commission

PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $33.53 Average PT from Brokerages

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has received a consensus recommendation of “Reduce” from the thirteen analysts that are currently covering the firm, Marketbeat reports. Five analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company. The average […]

United-states , Canada , China , Allan-steven-jacobson , Hexagon-capital-partners , Wells-fargo-company , Cantor-fitzgerald , Lazard-asset-management , Securities-exchange-commission , Morgan-stanley , Nisa-investment-advisors , China-universal-asset-management-co

PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Average Recommendation of "Reduce" from Brokerages

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has earned a consensus recommendation of “Reduce” from the fifteen brokerages that are presently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and three have issued a buy recommendation on the company. […]

Wellington , New-zealand-general- , New-zealand , Canada , Ohio , United-states , American , Matthewb-klein , American-international-group-inc , Goldman-sachs-group-inc , Royal-bank

PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $34.40 Average PT from Analysts

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has received a consensus recommendation of “Reduce” from the fifteen ratings firms that are currently covering the firm, Marketbeat reports. Five equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and three have assigned a buy recommendation to the […]

United-states , Canada , American , Pierre-gravier , Morgan-stanley , Royal-bank , Therapeutics-inc , Therapeutics-company-profile , Cantor-fitzgerald , American-international-group-inc , Nasdaq , Dimensional-fund-advisors

Insider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) Director Sells $273,800.00 in Stock

Insider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) Director Sells $273,800.00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China , Allan-steven-jacobson , Allspring-global-investments-holdings , Cantor-fitzgerald , Wells-fargo-company , Therapeutics-company-profile , Therapeutics-inc , Headlands-technologies , China-universal-asset-management-co , Nisa-investment-advisors , Lazard-asset-management , Barclays